Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNT1 | O60563 | 4/20 | 0.52 |
| ▸ | CDK9 | P50750 | 4/20 | 0.52 |
| ▸ | CDK2 | P24941 | 2/20 | 0.47 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.47 |
| ▸ | CDK4 | P11802 | 1/20 | 0.47 |
| ▸ | CCND1 | P24385 | 1/20 | 0.47 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.45 |
| ▸ | PIM1 | P11309 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6949785 | 0.91 | CCNT1 (0.54) | CCNT1CDK9CDK2CCNE2CDK4 | |
| SCHEMBL6952834 | 0.85 | CCNT1 (0.52) | CCNT1CDK9CDK2CCNE2CDK4 | |
| SCHEMBL7501550 | 0.85 | CCNT1 (0.49) | CCNT1CDK9CDK2CCNE2CDK4 | |
| SCHEMBL6949919 | 0.85 | CCNT1 (0.52) | CCNT1CDK9CDK2CCNE2CDK4 | |
| Enmd-981693 SCHEMBL29350364 | 0.85 | CCNE2 (0.69) | CDK2CCNE2CDK4CCND1CCNE1 | |
| SCHEMBL8476465 | 0.85 | CCNE2 (0.48) | CCNT1CDK9CDK2CCNE2CDK4 | |
| Enmd-981693 SCHEMBL608128 | 0.85 | CCNE2 (0.69) | CDK2CCNE2CDK4CCND1CCNE1 | |
| SCHEMBL6440413 | 0.82 | CCNE2 (0.58) | CDK2CCNE2CDK4CCND1CCNE1 | |
| Phosphoric Acid SCHEMBL6951263 | 0.81 | CCNT1 (0.47) | CCNT1CDK9CDK2CCNE2CDK4 | |
| SCHEMBL7500940 | 0.80 | CCNT1 (0.46) | CCNT1CDK9CDK2CCNA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1224181-B1 | SUBSTITUTED PYRROLES AS ANTIPROLIFERATIVE AGENTS FOR THE TREATMENT OF CANCER | HOFFMANN LA ROCHE (CH) | 2003-12-03 | — | — | EP | claimed |